JPRN-UMIN000014332已完成未知
Phase II study of neoadjuvant chemotherapy of TS-1, CDDP and Paclitaxel for resectable large type 3 or type 4 gastric cancer - Phase II study of neoadjuvant chemotherapy of TS-1, CDDP and Paclitaxel for advanced gastric cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) with severe drug allergy 2) with highly lymph node metastases 3) with severe infection 4) with severe diarrhea 5) with severeintestinal paralysis or ileus 6) with interstitial pneumonia or pulmonary fibrosis with other active malignant disease 7) with active other malignancy 8) with severe diabetes 9 ) with severe heart disease 10) pregnant or nursing women or women who like be pregnant and willing to get pregnant
研究者
相似试验
未知
不适用
Phase II study of neoadjuvant chemotherapy TS-1/CPT-11 for advanced lower rectal cancersRectal cancersJPRN-UMIN000000962Dept. Surgery Kyoto University Hospital25
已完成
2 期
Phase II study of TS-1 chemotherapy as adjuvant treatment after resection of hepatic metastases from colorectal cancerliver metastases of colorectal cancerJPRN-UMIN000001498agoya Surgical Oncology Group60
招募中
不适用
PhaseII trial of neoadjuvant chemotherapy with TS-1, Oxaliplatin and Bevacizumab for resectable liver metastases from colorectal cancerResectable colorectal liver metastasesJPRN-UMIN000004706agoya Surgical Oncology Group60
已完成
2 期
Clinical study of Adjuvant chemotherapy with TS-1 for breast cancerbreast cancerJPRN-UMIN000011860Breastopia Namba Hospital380
已完成
不适用
Phase II study of neoadjuvant chemotherapy with the FEC followed by weekly nab-Paclitaxel(nanoparticle albumin-bound paclitaxel) for the operable breast cancer (KSCOG-BC07)Breast CancerJPRN-UMIN000010504Department of Surgery Kurume University School of Medicine30